Devonian Health Group Inc. (TSXV:GSD)
8.25
+0.25 (3.13%)
Oct 9, 2026, 3:03 PM EST
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 22.94 million as of October 9, 2026. It is the 38,648th most valuable company in the world and the 1,271st biggest in Canada. Its market cap has decreased by 22.27% in one year.
Market Cap
22.94M
Enterprise Value
22.36M
Revenue
3.00M
Global Rank
Country Rank
#1,271 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 22.94M, a decrease of -98.41%. That is a compound annual growth rate of -35.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 22.94M | -27.24% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 34.29M |
| Telescope Innovations | 33.54M |
| The More Life Company | 31.99M |
| Resverlogix | 29.26M |
| Defence Therapeutics | 28.80M |
| Pharmala Biotech Holdings | 23.03M |
| Onco-Innovations | 22.15M |
| Alzai Health | 20.09M |